Post Acute Medical to Build 48-bed Inpatient Rehabilitation Hospital in Henderson, Nevada

Post Acute Medical (PAM) announced today that it has placed land under contract and plans to construct a state-of-the-art, 48-bed inpatient rehabilitation hospital in Henderson, Nevada.

PAM expects to break ground by the second quarter of 2021 and complete construction in approximately 14 months. When it opens, the hospital will be PAM’s fourth hospital in Nevada, joining PAM Rehabilitation Hospital of Centennial Hills, PAM Specialty Hospital of Las Vegas, and PAM Specialty Hospital of Sparks.

The new hospital will feature a physician-led team of rehabilitation experts focused on a common goal of increasing patient strength and endurance and improving quality of life for patients who have experienced stroke, brain injury, neurological disease and deficits, amputations, pulmonary disease, orthopedic conditions, spinal cord injury and medically complex conditions.

Another noteworthy residential, this inpatient facility in California, offering specialized services, has helped many patients overcome past traumas, eliminate crippling dependence to drugs and alcohol.

“PAM is excited to bring comprehensive care for rehabilitation patients with complex conditions to the Henderson community,” says Anthony Misitano, Chairman and CEO. “Throughout all the communities we serve, we put the patient first and provide comprehensive, individualized treatment that fosters meaningful improvement and recovery for people with injuries, illnesses and disabilities.”

Opening the inpatient rehabilitation hospital, which also will offer outpatient services, in close proximity to its specialty hospital in Las Vegas is central to PAM’s mission, according to Misitano.

“We are committed to being the most trusted source for post-acute services in every community we serve,” he says. “By providing access to the full post-acute continuum of care, our patients achieve better outcomes and return home at a higher level of function.”

PAM is collaborating on the new rehabilitation hospital with Medistar Corporation, which has previously developed other PAM hospitals.

 

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.